Wuhan Pusheng Pharmaceutical Co., Ltd.

Wuhan Pusheng Pharmaceutical Co., Ltd. was established in 1984. It currently has 240 employees and 140 mu of land. Its business scope covers the production and sales of lyophilized powder injections, powder injections, and active pharmaceutical ingredients. It has 36 varieties and 53 specifications, including 12 new drugs and 14 products listed in the National Essential Medicines List. The company's various drugs are sold across the country, and its products remain in short supply. Sales revenue and profits and taxes have increased year after year. It is a National High-tech Enterprise, one of the first batch of innovative pilot enterprises in Hubei Province, an innovative pilot enterprise in Wuhan City, a provincial AAA credit-rated enterprise, a provincial second-level enterprise for work safety standardization, a provincial contract-abiding and credit-reliable enterprise, and a provincial-level civilized unit. For many consecutive years, it has been awarded honorary titles such as "Major Taxpayer," "Key Taxpayer," "Red Flag Unit," and "Advanced Unit" by the Jiangxia District Government. In the Pusheng Pharmaceutical Park in Jiangxia District, the company has four production lines for active pharmaceutical ingredients, cephalosporin powder injections, lyophilized powder injections, and sterile powder injections. Among them, the lyophilization area is 220 square meters, and the cephalosporin workshop is the only one in Hubei. Its annual output of lyophilized and cephalosporin powder injections is 100 million vials, the largest scale in Hubei Province, and its production capacity ranks among the top in the country.